Conventus Law - www.conventuslaw.com
  • Home
  • About Us
    • Contact Us
  • Membership
  • Reports & Analysis
    • News
  • Videos
  • Events
India – Intellectual Property – November 2014

 

  • The Delay In Generic Drug Approvals By The US FDA Likely To Hurt Indian Pharma.
  • 78% Of The Patent Filings In Country By Non-Residents.
  • The India-US Trade Policy Forum (TPF) To Be Held In Delhi.
  • Delhi High Court Orders Status Quo In Burger King Case: No New Legal Proceedings To Be Initiated.
  • SRI Rajesh Kumar Banka V. Union Of India: Calcutta High Court Quashes IPAB Revocation Order.
  • Treasuring The Secret: Need For IP Based Protection To Trade Secrets.
  • To Be Or Not To Be: Parallel Imports Of Publications.
  • Chances Of Rejection Of Trademark “Amma Mineral Water”.
  • MoU Between EPO And IPO To Foster Innovation.
  • Important Ruling On Section 8 Of The Patents Act, 1970.
  •  Dispute Over Trademark ‘Khadi’.
  • Roche And Cipla Will Battle It Out In The Court: Mediation Over Erlotinib Fails.
  • Guidelines For Examination Of Patent Applications In The field Of Pharmaceuticals Launched By CGPDTM.
  • Cipla Asks Government To Cancel Novartis Patents On Respiratory Drug.
  • Stakeholders’ Submit Their Responses On Special 301 Out Of Cycle Review.
  • Government Constitutes A Think Tank To Draft A National IPR Policy.

Comments are closed.

In-House Lawyer Profiles
Sharyn Ch’ang
PWC, Director, Global Office of the General Counsel
read more
Wesley Chiu
SCA Asia Pacific, General Counsel, Shanghai
read more
Kapil Kirpalani
Pacific Harbor Capital, Legal and the Chief Compliance Officer, Hong Kong
read more
click here for the full list
  • Conventus Law Monthly Round Up
  • Home
  • About Us
    • Contact Us
  • Membership
  • Reports & Analysis
    • News
  • Videos
  • Events
| Privacy Statement | Terms and Conditions
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok